Ledger.Open graph →

SEC Form D · filed May 22, 2019

Veralox Therapeutics Inc

Offering

$4.0M

Sold

$1.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

FREDERICK, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Jeffrey W. Strovel · Frederick, MDExec · Director Marc K. Furstein · New York, NYExec · Director Matthew W. Boxer · Frederick, MDExec · Director David W. Maloney · Frederick, MDExec · Director Jonathan W. Behr · Boston, MADirector Milena Alberti · Cleveland, OHExec · Director David W. Maloney · Frederick, MDExec · Director Jonathan W. Behr · Boston, MADirector Matthew W. Boxer · Frederick, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗